These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18212182)

  • 1. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 3. Valproic acid-induced hyperammonemia: a case report.
    McCall M; Bourgeois JA
    J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonemic encephalopathy.
    Yehya N; Saldarini CT; Koski ME; Davanzo P
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):926-7. PubMed ID: 15266186
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of valproic acid poisoning treated with L-carnitine.
    Chan YC; Tse ML; Lau FL
    Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    Sonik P; Hilty DM; Rossaro L; Bourgeois JA
    J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
    [No Abstract]   [Full Text] [Related]  

  • 13. Lesson of the month 1: Sodium valproate-induced encephalopathy.
    Camilleri L
    Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.
    Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M
    Medicine (Baltimore); 2017 Sep; 96(39):e8117. PubMed ID: 28953637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
    Panikkar GP; Gilman SM
    J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
    [No Abstract]   [Full Text] [Related]  

  • 18. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A; Siddu A; Sardu C; Sarnicola A; Martinelli V
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
    de Leon J; Diaz FJ; Spina E
    J Clin Psychiatry; 2010 Jul; 71(7):957-8; author reply 958-9. PubMed ID: 20667295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.